Investigational Treatment Regimen Could Expand Options for Virologically Suppressed Adults –– Positive Phase 3 Results from ...

NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026FORT ...

The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of ...

FutureWise Research, a leading provider of strategic market intelligence, has published an in-depth new market analysis ...

OrganaBio, LLC, a leading provider of human research- and clinical-grade cellular starting materials and clinical trial support services today announced the opening of its newest cell processing and ...

OlivePoint Capital (“OlivePoint”), an institutional real estate investment manager focused on thematic and special situations strategies, and Redwood Capital Management, LLC, a global alternative ...

The "Tourette Syndrome Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering.The Tourette Syndrome Drugs Market is projected to witness ...

Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients with AML, ALL and MDS compared to a conventional allogeneic hematopoietic stem cell ...

Ophidion, Inc., a biotechnology company pioneering non-invasive delivery of gene-silencing and large-molecule therapeutics to the brain, and Neuronasal, Inc., a clinical-stage company advancing ...

Matrix One, a leading digital solution provider for the medical devices and life sciences industry and backed by Lauxera Capital Partners, announces today the acquisition of dokspot GmbH, a pioneering ...

Company experts elevate best practices in patient access, AI innovation, gross-to-net management, and copay strategyWHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx, a leading provider of ...

Scribe Therapeutics Inc. (Scribe), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...